Funding news
Resynergi logo

Resynergi Raises $18M in Series B Funding to Transform Plastic Waste into a Circular Future

Recently funded · $18.0M Series bPlastics/Environmental Services

Get the full Resynergi company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Resynergi is excited to announce a major milestone in our journey toward a sustainable future—we have successfully raised $18,000,000 in new funding. This significant investment marks a pivotal step in our mission to accelerate the world’s transition to a circular economy. At Resynergi, we are driven by the vision of transforming the way our society views plastic waste. Instead of allowing plastics to end up in landfills or pollute our environment, we employ innovative technologies to convert hard-to-recycle plastic waste back into its molecular building blocks. This breakthrough process enables us to transform what once was considered problematic waste into valuable feedstock for new plastic products, effectively turning a major environmental challenge into an opportunity for sustainable reuse.

The funds raised will be strategically directed toward scaling up our recycling technology, enhancing our production capacity, and expanding our market reach. With this investment, we plan to accelerate research and development efforts, explore new applications for reclaimed materials, and forge partnerships with industry leaders committed to a circular economy. Our ultimate goal is to reduce society's reliance on petroleum-based plastics by providing a circular alternative that champions environmental stewardship and economic innovation.

We believe that every piece of plastic waste has the potential to become a building block for a cleaner, healthier future, and with your support, we are one step closer to realizing that vision. Join us as we continue our journey to change perspectives, reimagine waste, and create a sustainable legacy for future generations.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
ChAbS (Chinese Antibody Society) logo

ChAbS (Chinese Antibody Society)

United States

$101.0M
2
EqualAI logo

EqualAI

United States

$30.0M
3
PhoenixAI logo

PhoenixAI

United States

$80.0M
4
Coram AI logo

Coram AI

United States

$35.0M
5
City Therapeutics logo

City Therapeutics

$99.5M